NY-CANVA
17.6.2024 07:01:32 CEST | Business Wire | Press release
Canva, the world’s only all-in-one visual communication platform, and MMA Global, the leading global trade association for marketers, today released joint research on the value of creative output, tech stack saturation and navigating talent wars.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240616737948/en/
Creative Output is the New Gold Standard (Graphic: Business Wire)
Canva and the MMA surveyed nearly 100 CMOs and senior marketers in decision-making roles from the U.S. and the U.K, and found that in today’s hyper competitive brand world, more than three-quarters (77%) believe creative output — encompassing all elements of campaigns and content — is more crucial now than ever before, with 69% saying that creative is a top marketing priority in their organization.
The survey revealed a variety of external forces fueling creativity in new ways, and a number of obstacles blocking marketers from unlocking full creative potential. Top findings include:
Creative Output is the New Gold Standard
Marketing leaders are placing increasing value on creative, and there’s expectation this trend will continue.
- More than two-thirds (68%) believe that creative will become more important to their organization in the next 12 months.
- 72% believe that creative output adds value to customers' lives.
But Creative Investment is Falling Short of Proven Worth
Despite the increasing value placed on creative, there is a significant gap in investment.
- More than half (55%) invest 10 to 25% of their total marketing budget on creative, while nearly a fifth (18%) invest less than 10% on creative.
- 41% say they aren’t making the right level of investment in creative tools, systems and technologies.
The Creative Process Has Increased in Complexity
Today’s ecosystem of creative tools is bringing plenty of improvements, but not without new challenges.
- The following elements are ranked as more challenging now (46%) than they were five years ago: managing resources and budgets, maintaining consistency of output, and managing systems and tools.
- Most positive benefits come from the following tools, either by increasing efficiency or improving the creative output: collaboration platforms (54%), photo/video editing tools (54%), generative AI tools (35%).
Keeping Pace with Technological Advances is a Struggle
Marketing leaders are mostly confident in their creative output when compared to competitors, but there are areas where they feel outpaced.
-
Comparing their creative output and processes to competitors:
- 34% believe their creative output is better, and 53% believe it’s on par.
- 45% believe they’re worse at managing a creative process that optimizes for speed, efficiency and flexibility.
In-House Model Gains in Appeal
The landscape of creative management is shifting with more work being brought in-house vs. outsourced to agencies. In-sourcing is mostly seen as a superior process for teams, but outsourcing is used when there is a need to collaborate on high impact creative output.
- 30% have moved more work in-house in the last 12 months, and 31% expect to do the same in the next year.
- 48% say creative strategy is mostly done in-house, while 23% say it’s mostly outsourced.
- 83% say that in-house is better from a cost perspective, while 61% say that outsourcing is better for quality of creative output.
Pool for Top Creative Talent Is Shrinking
There’s concern about a diminishing pool of strong creative talent, underscoring the challenge of securing, managing and retaining talent in a competitive market.
- 47% say the pool of strong talent has gotten smaller.
- 80% feel satisfied with outsourced creative talent and resources; while 74% feel satisfied with in-house creative talent or resources.
“Producing stellar creative output while optimizing for resource efficiency is a massive challenge for every modern marketer today. How brands show up has gotten more competitive, there is a lot of tech to wade through, and the talent pool is narrowing,” said Canva CMO Zach Kitschke. “We’re delighted to work with the MMA team to identify the pain points and opportunities that marketers are facing today, in order to shed light on top-of-mind issues to inform their decision making.”
“While the last few years might seem solely focused on perfecting data, audience development, and targeting to drive outcomes, marketers are also recognizing the need to focus on a second creative revolution,” said MMA Global CEO Greg Stuart. “Marketers face a pivotal moment where embracing AI and the challenge of managing the Brand via what can be thousands of executions will redefine creativity’s role and brand communication, demanding a new and updated focus to managing the creative process.”
Access “The State of Creative Process in Marketing" here.
About Canva
Launched in 2013, Canva is a free online visual communications and collaboration platform with a mission to empower everyone in the world to design. Featuring a simple drag-and-drop user interface and a vast range of templates ranging from presentations, documents, websites, social media graphics, posters, apparel to videos, plus a huge library of fonts, stock photography, illustrations, video footage, and audio clips, anyone can take an idea and create something beautiful.
Canva offers a variety of tools purpose-built for marketers. In recent years, Canva has introduced a number of products and services to help marketers and creatives unlock new levels of creativity, collaborate more effectively, and scale content creation. This includes Canva Teams, the newly introduced Canva Enterprise offering, Brand Kit, and Marketing Work Kits.
About MMA Global
MMA Global is a non-profit trade association dedicated to Architecting the Future of Marketing while Relentlessly Delivering Growth Today. Our Prime Audience is Pioneering Chief Marketers; our Purpose is to enable marketers to drive innovation and enduring business value in an increasingly dynamic and ultra-connected world. The MMA has 800+ corporate members in over three dozen countries and is a truly global organization with offices in 14 countries throughout APAC, EMEA, LATAM, and North America. While the MMA is run and controlled by Marketers, it is the only Marketing-oriented trade body to include all aspects of the ecosystem: Media Companies, Enabling MarTech & AdTech, Platforms, Consultancies, and Agencies. This gives us the perspective to tackle industry issues comprehensively.
Methodology
The study used an online questionnaire. Fieldwork was conducted in May 2024, among large marketers (72% have revenues over $1BN), across a variety of sectors. Respondents were senior marketers (C-Level 32%, EVP/SVP/VP 35%, Other senior 32%).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240616737948/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
